Drug Discovery & Development | Agenus, Ludwig to Advance Antibodies into Development Drug Discovery & Development Ludwig Cancer Research and Agenus Inc. announced the selection of three monoclonal antibody checkpoint modulators (CPMs) that Agenus is advancing into preclinical development. These product candidates—two GITR agonists and a CTLA-4 ... |
